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Many cellular processes are regulated by the ubiquitin–proteasome system. Therefore, it is not surprising
that viruses have adapted ways to manipulate the ubiquitin–proteasome system to their own advantage.
p28 is a poxvirus encoded ubiquitin ligase that contains an N-terminal KilA-N DNA binding domain and
a C-terminal RING domain required for ubiquitin ligase activity. p28 is encoded by a wide range of
poxviruses, including members of the Avipoxviruses. Here we show that fowlpox virus (FWPV) and
canarypox virus (CNPV) each contain two distinct p28-like ubiquitin ligases; an observation not seen in
other members of the poxvirus family. FWPV150 and FWPV157 are both ubiquitinated during infection
and co-localize with conjugated ubiquitin at the viral factory. Interestingly, we demonstrate that
FWPV150 was actively transcribed early, while FWPV157 was expressed late. Overall, these observations
suggest different temporal roles for FWPV150 and FWPV157, an observation unique to the Avipoxviruses.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The Poxviridae are a family of large double-stranded DNA
viruses ranging from 150 to 300 Kbp that infect humans and a
wide range of animals (Moss, 1996). Variola virus is the causative
agent of smallpox, the most infamous member of the Orthopox-
virus genus as it was responsible for 300–500 million deaths
during the 20th century (Moss, 1996). Within the same genus, the
highly related vaccinia virus (VACV) was used to eradicate small-
pox, and is now commonly used as a laboratory strain to study
virus–host interactions (Wehrle, 1980). Other members include
ectromelia virus (ECTV), the causative agent of mousepox, cowpox
virus (CPXV), myxoma virus (MYXV), and monkey poxvirus
(MPXV) (Moss, 1996). The central region of the genome is ﬂanked
by variable regions that deﬁne host-range, virulence, and immune
evasion, allowing poxviruses to encode a remarkable variety of
mechanisms to elude immune detection (Johnston and McFadden,
2003; Seet et al., 2003). Given the wide array of processes that
regulate ubiquitination it is not surprising that many viruses,
including poxviruses, have developed strategies to manipulate
the ubiquitin–proteasome system to their own advantage (Gustin
et al., 2011; Isaacson and Ploegh, 2009; Randow and Lehner, 2009).
Ubiquitin is a 76 amino acid protein that is highly conserved
among eukaryotes, with only three amino acid differences
between yeast and human (Weissman, 2001). Ubiquitin serves as
a post-translational modiﬁcation that covalently attaches to lysine
residues. There are seven lysine residues in ubiquitin (K6, K11, K27,
K33, K29, K48 and K63), all of which have the potential to support
the formation of poly-ubiquitin chains (Komander, 2009; Pickart
and Fushman, 2004; Weissman, 2001; Weissman et al., 2011).
Ubiquitination is a multi-step process that can alter the fate of
protein substrates (Komander, 2009; Pickart and Fushman, 2004;
Weissman, 2001; Weissman et al., 2011). Mono-ubiquitination can
lead to endocytosis, or a change in the cellular localization of the
protein (Hicke, 2001), whereas the addition of poly-ubiquitin
chains leads to different outcomes dependent on the type of the
ubiquitin chain (Komander, 2009; Pickart and Fushman, 2004). For
example, lysine 63 chains modulate protein function in a non-
proteolytic manner, and lysine 48 ubiquitin chains typically mark
proteins for proteasomal degradation (Komander, 2009; Pickart
and Fushman, 2004). Ubiquitination occurs as an enzymatic
cascade that includes an E1 activating enzyme, an E2 conjugating
enzyme, and an E3 ubiquitin ligase (Weissman, 2001). Ultimately,
the E3 ubiquitin ligase is responsible for substrate speciﬁcity. Since
a ﬁne balance is necessary to maintain an appropriate protein level
in the cell, the addition of ubiquitin to substrates is tightly
regulated to avoid cellular dysfunction and diseases such as
neurodegenerative disorders and cancer (Bedford et al., 2011;
Ciechanover, 2012; Crusio et al., 2010).
Our work and others have shown that p28 functions as an E3
ubiquitin ligase (Huang et al., 2004; Nerenberg et al., 2005;
Senkevich et al., 1994, 1995). p28 was ﬁrst identiﬁed in Shope
ﬁbroma virus (N1R) (Brick et al., 1998). N1R was initially mistaken
as a nonessential gene, since no homologue was found in
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VACVCop and only a truncated version was present in VACVWR
(Nerenberg et al., 2005; Senkevich et al., 1994). However, Buller
and colleagues demonstrated that p28(ECTV) functions as a
virulence factor (Brick et al., 1998; Senkevich et al., 1994, 1995).
Mice survived infection with ECTV devoid of p28, demonstrating a
dramatic reduction in virulence compared to wild type ECTV
infection, owing to the inability of the knockout virus to replicate
in macrophages (Senkevich et al., 1994).
The p28 ubiquitin ligase consists of two highly conserved
functional domains including a RING domain, which contains the
E3 ubiquitin ligase activity, and a KilA-N domain that is largely
uncharacterized but contains a DNA binding domain (Iyer et al.,
2002). The KilA-N domain has been found in large DNA viruses,
bacteria and bacteriophages and interacts with DNA (Nerenberg et
al., 2005). Previous work demonstrated that the KilA-N domain is
responsible for localization of p28 at the virus factories. A
conserved region of seven amino acid residues (44-50 YINITKI) is
crucial for p28 localization to the virus factory and constructs
lacking amino acids 44–50 were unable to localize to viral factories
(Johnston and McFadden, 2003). p28 homologues are found in
a wide range of viruses including VACV(IHDW), myxoma virus,
variola virus, and cowpox virus (www.poxvirus.org). In addition to
p28, other members of the Poxviridae family encode a membrane
associated RING-CH (MARCH) ubiquitin ligase, M153R, which
degrades cell surface immune molecules such as MHC class I,
CD4, and ALCAM(CD166) (Bartee et al., 2006; Mansouri et al.,
2003). Interestingly, Avipoxviruses, such as CNPV and FWPV, are
the only known poxviral members that contain two distinct
homologues of p28 (Afonso et al., 2000; Tulman et al., 2004).
Fowlpox (FWPV) is the prototypical member of the Avipoxvirus
genus infecting mostly chickens and turkeys (Afonso et al., 2000).
Infection typically leads to lesions and scabs on the skin and in
severe cases leads to lesions in the upper gastrointestinal and
respiratory tracts (Tripathy and Hanson, 1978). FWPV transmission
occurs via contact and shedding from lesions due to increased
stress (Tripathy and Hanson, 1978). FWPV poses a serious agricul-
ture problem in poultry houses as it leads to decreased ﬂock
performance and egg production resulting in signiﬁcant economic
loss (Tripathy and Hanson, 1978). However, vaccines are available
in the form of attenuated FWPV (Beukema et al., 2006; Skinner
et al., 2005). Avipoxviruses like FWPV and CNPV are also suitable
candidates for safe vaccination vectors in humans since they infect
mammalian cells and only express early proteins and replication is
aborted due to restricted host range (Odunsi et al., 2012). FWPV
and CNPV are the best-characterised members of the Avipoxvirus
family (Afonso et al., 2000; Tulman et al., 2004). Most of their
host-range and immune evasion genes still remain unexplored.
Here we show that FWPV encodes two functional p28-like
ubiquitin ligases, a unique observation within the Poxviridae
family (Afonso et al., 2000; Tulman et al., 2004). Signiﬁcantly,
both FWPV150 and FWPV157 are expressed during FWPV infec-
tion and co-localize with conjugated ubiquitin at the virus factory.
We demonstrate that both FWPV150 and FWPV157 are ubiquiti-
nated during poxvirus infection. Interestingly, our data indicate
that FWPV150 is expressed early, while FWPV157 is expressed late
during infection. Together, our data suggests that both FWPV150
and FWPV157 act as functional ubiquitin ligases and are regulated
by ubiquitination. The difference in temporal expression further
suggests a speciﬁc role for both FWPV150 and FWPV157; an
observation not previously seen in other poxvirus genomes.
Results
Mammalian and avian poxviruses do not inhibit the proteasome
system
The ubiquitin–proteasome system has emerged as an impor-
tant mechanism to control protein degradation (Pickart and
Fushman, 2004; Weissman, 2001). Recently, it has become appar-
ent that poxviruses use the ubiquitin–proteasome system in order
to manipulate host responses (Barry et al., 2010; Gustin et al.,
2011; Isaacson and Ploegh, 2009; Randow and Lehner, 2009;
Zhang et al., 2009). Furthermore, it has been shown that a
functioning proteasome is important for poxvirus replication,
while most other cellular functions are shut down by poxvirus
infection (Satheshkumar et al., 2009; Teale et al., 2009). Therefore,
we sought to determine if the proteasome was functional during
poxvirus infection, including members of mammalian and avian
poxviruses. The chymotrypsin-like activity of the proteasome was
assessed in HeLa cells or QM5 quail cells that were mock-infected
or infected with VACVCop, ECTV(Moscow), CPXV(Brighton Red),
and one Avipoxvirus member, FWPV (Fig. 1A and B). Mock-infected
cells demonstrated high luminescence corresponding to the
amount of chymotrypsin-like activity of the proteasome (Fig. 1A).
Similarly, cells infected with VACVCop, CPXV, or ECTV demon-
strated considerable proteasome activity with only a small sig-
niﬁcant difference between mock and infected cells (po0.0056)
Fig. 1. Mammalian and Avian poxviruses do not inhibit the proteasomal system. (A) HeLa cells were mock-infected or infected with VACVCop, ECTV, or CPXV at an MOI of 10
for 14 h and at 12 h post-infection treated with or without 10 μMMG132. Proteasomal function was quantiﬁed by Proteasome-Glo assay (Promega), and standard deviations
were calculated from three independent experiments. (B) QM5 cells were infected with FWPV at an MOI of 10 for 14 h and at 12 h post-infection treated with or without
10 μM MG132. Proteasomal function was quantiﬁed by Proteasome-Glo assay. Standard deviations were calculated from three independent experiments.
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(Fig. 1A). Infected cells treated with MG132 resulted in less than 1%
proteasome activity with a high signiﬁcant difference (po0.0001),
which was also exhibited by mock-infected cells treated with
MG132 (Fig. 1A). Although some decrease in proteasome function
was evident late during VACV, CPXV, and ECTV infection, the
chymotrypsin-like activity of the proteasome remained functional
(Fig. 1A). To further investigate the proteasome activity during
poxvirus infection we focused on FWPV; a divergent member of
the poxvirus family (Fig. 1B). Mock-infected QM5 quail cells
demonstrated proteasome activity that was signiﬁcantly inhibited
in the presence of MG132 (po0.0001) (Fig. 1B). FWPV infection
demonstrated a non-signiﬁcant loss of proteasome function in
QM5 cells compared to uninfected cells (po0.1). Overall, these
results reveal that the proteasome function is not impaired over
the course of VACV, CPXV, ECTV and FWPV infection, and the
addition of MG132 inhibited the proteasome, as expected.
FWPV and CNPV encode p28-like ubiquitin ligases
Poxviruses promote infection by expressing a variety of effector
proteins (Johnston and McFadden, 2003; Seet et al., 2003). For
example, ECTV encodes the virulence factor p28 that functions as a
ubiquitin ligase (Senkevich et al., 1994, 1995). Homologues of p28
are encoded by a wide range of poxviruses including ECTV, IHDW
and CPXV, each encoding a single homologue. In contrast, mem-
bers of the Avipoxvirus family, such as FWPV and CNPV, encode
two homologues of p28-like ubiquitin ligases that have not been
thoroughly investigated (Afonso et al., 2000; Tulman et al., 2004).
Compared to p28(IHDW) and p28(ECTV), the sequence identity of
FWPV150, FWPV157, CNPV197, and CNPV205 demonstrates 23%,
43%, 43%, and 42% sequence identity. The sequence identity
between FWPV150 and FWPV157 is 35%, whereas the sequence
identity between CNPV197 and CNPV205 is 36%. Signiﬁcantly, the
cysteine and histidine residues within the RING domain were
previously shown to be critical for ubiquitin ligase activity (Huang
et al., 2004) and are highly conserved among the four Avipoxvirus
proteins (Fig. 2). Additionally, residues 44–50 within the KilA-N
domain are crucial for DNA binding, were similar among the four
proteins. Therefore we sought to investigate if both ubiquitin
ligases, FWPV150 and FWPV157, functioned during infection.
FWPV150 and FWPV157 localize to viral factories during infection
Previous studies have demonstrated that p28(IHDW) localizes
to viral factories (Nerenberg et al., 2005). Given the conservation
of key residues among p28(IHDW), FWPV150 and FWPV157, we
sought to investigate whether FWPV150 and FWPV157 localize to
virus factories. HeLa cells were mock-infected (Fig. 3A, panels a–d),
infected with VACVCop (Fig. 3A, panels e–h), or infected with
VACVCop and transfected with pSC66-Flag-FWPV150 (Fig. 3A,
panels i–l) or pSC66-Flag-FWPV157 (Fig. 3A, panels m–p). DAPI
was used to visualize both the nucleus and cytoplasmic virus
factories and I3L was used as a marker. Staining for Flag visualized
FWPV150 and FWPV157. Using this approach, we observed that
both FWPV150 and FWPV157 localize to virus factories during
VACVCop infection. Given that p28(IHDW) co-localizes with con-
jugated ubiquitin (Nerenberg et al., 2005), we determined if
FWPV150 and FWPV157 co-localize with ubiquitin. HeLa cells
Fig. 2. Alignment of p28 homologues in FWPV and CNPV demonstrates conservation of the KilA-N and RING domains. Protein alignments for p28(IHDW), p28(ECTV),
FWPV150, FWPV157, CNPV197 and CNPV205 were performed via Clustral W (1.82) (http://www.ebi.ac.uk/clustalW/#) (Chenna et al., 2003). The KilA-N domain is underlined
in black and the RING domain is underlined in grey. Asterisks highlight the conserved cysteines and histidines within the RING domain.
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were mock-infected (Fig. 3B, panels a–d), or infected with VACV-
Cop (Fig. 3B, panels e–h). To investigate the localization of p28-like
proteins, HeLa cells were infected with VACVCop and transfected
with pSC66-Flag-p28(IHDW) (Fig. 3B, panels i–l), pSC66-Flag-
FWPV150 (Fig. 3B, panels m–p), or pSC66-Flag-FWPV157 (Fig. 3B,
panels u–x). We included mutant versions of both FWPV150 and
Fig. 3. FWPV150 and FWPV157 localize to viral factories. (A) HeLa cells were mock-infected or infected with VACVCop at an MOI of 5 and transfected with pSC66-Flag-FWPV150 or
pSC66-Flag-FWPV157 for 14 h. Cells were ﬁxed and stained for DAPI to visualize nuclei and virus factories. (B) HeLa cells were mock-infected or infected with VACVCop at an MOI
5 and transfected with pSC66-Flag-p28, pSC66-Flag-FWPV150, pSC66-Flag-FWPV150(C196S/C199S), pSC66-Flag-FWPV157, or pSC66-Flag-FWPV157(C218S/C221S). Cells were ﬁxed
and treated with DAPI, to visualize the nucleus and virus factories, and stained with anti-Flag to visualize Flag-tagged proteins and anti-FK2 to recognize conjugated ubiquitin. Co-
localization was visualized by confocal microscopy. (C) QM5 cells were mock-infected or infected with FWPV at an MOI of 5 and transfected with pSC66-Flag-FWPV150, pSC66-
Flag150(C196S/C199S), pSC66-Flag-FWPV157, or pSC66-Flag-FWPV157(C218S/C221S). Cells were ﬁxed and treatedwith DAPI, to visualize the nucleus and virus factories, and stained
anti-Flag to visualize Flag-tagged proteins and anti-FK2 to recognize conjugated ubiquitin. Co-localization was visualized by confocal microscopy.
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FWPV157 containing two disrupted cysteine residues in the RING
domain, FWPVC196S/C199S and FWPVC218S/C221S (Fig. 3B,
panels q–t and panels y–bb). Cells were stained with DAPI and
co-stained with anti-Flag to visualize FWPV150, FWPV157,
FWPV150(C196S/C199S), FWPV157(C218S/C221S) and anti-FK2 to
visualize conjugated ubiquitin (Weissman, 2001). As expected,
infection with VACVCop resulted in a lack of conjugated ubiquitin
at the virus factory (Fig. 3B, panel f). In contrast, p28(IHDW) co-
localized with conjugated ubiquitin at the virus factories (Fig. 3B,
panels i–l). In a similar manner, FWPV150, FWPV157, FWPV150
(C196S/C199S), and FWPV157(C218S/C221S) also co-localized with
conjugated ubiquitin at the virus factories upon disruption of the
RING domain function (Fig. 3B, panels t and bb). Taken together,
these data indicate that the accumulation of conjugated ubiquitin
at the virus factory occurs in p28(IHDW), FWPV150 and FWPV157
upon disruption of the RING domain.
Our previous experiments were conducted in HeLa cells during
VACV infection, we next used QM5 quail cells to determine if
conjugated ubiquitin was found at the virus factory during FWPV
infection. QM5 cells were mock-infected (Fig. 3C, panels a–d),
infected with FWPV (Fig. 3C, panels e–h), and infected with FWPV
and transfected with pSC66-FWPV-Flag-FPV150 (Fig. 3C, panels i–
l), pSC66-FWPV-Flag-150(C196S/C199S) (Fig. 3C, panels m–p),
pSC66-FWPV-Flag157 (Fig. 3C, panels q–t) or pSC66-FWPV-Flag-
157(C218S/C221S) (Fig. 3C, panels u–x). Cells were co-stained with
anti-Flag to visualize FWPV150 (Fig. 3C, panel k), FWPV157
(Fig. 3C, panel s), FWPV150(C196S/C199S) or FWPV(C218S/C221S)
and with FK2 to detect conjugated ubiquitin (Fig. 3C, panels b, f, j,
n, r, v). Infection with wildtype FWPV resulted in a modest
accumulation of conjugated ubiquitin at viral factories (Fig. 3C,
panel f). FWPV150 and FWPV157 co-localized with conjugated
ubiquitin at the viral factories (Fig. 3C, panels l and t). To further
Fig. 4. FWPV150 and FWPV157 are regulated by ubiquitination. (A) To detect ubiquitination HeLa cells (2106) were mock-infected or infected with recombinant virus
VACV-HA-Ub, expressing HA-tagged ubiquitin, at an MOI of 5 and transfected with pSC66-Flag-p28, pSC66-Flag-FWPV150, (10 mM) for 6 h. Cells were lysed in RIPA buffer,
containing 5 mM NEM, and Flag-tagged proteins were immunoprecipitated with mouse anti-Flag M2 and western blotting with mouse anti-Flag to detect ubiquitination. To
further visualize ubiquitination, the Flag-tagged proteins were immunoprecipitated with mouse anti-Flag M2 and (B) western blotted with mouse anti-HA, or (C) were
western blotted with mouse anti-ubiquitin. * Indicates ubiquitination in (A) correlating with higher molecular weight bands in (B). HC stands for heavy chain and LC for light
chain. in vitro ubiquitin ligase activity of p28, FWPV150, and FWPV157 (D). Protein G beads containing Flag tagged proteins were combined in an in vitro ubiquitination
reaction with E1, (E2), ATP, and biotin-labeled ubiquitin (BIOMOL International). Reactions were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and
were probed with streptavidin-tagged HRP. Western blotting shows the appearance of high-molecularmass ubiquitin adducts in reactions containing either p28, FWPV150,
or FWPB157 compared to reactions with no input, GST alone, the double mutants of p28(C173S/C176S), FWPV150(C196S/C199S), or FWPV157(C218S/C221S).
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Fig. 5. FWPV150, FWPV157 and double-cysteine mutants co-localize with HA-Ub and HA-K48-Ub. HeLa cells were infected with VVT7 (WR strain) at an MOI of 5 and
transfected with either pBluescript-HA-Ub, pBluescript-HA-K48-Ub, and either with pSC66-Flag-FWPV150, pSC66-Flag-FWPV150(C196S/C199S), pSC66-Flag-FWPV157, or
pSC66-Flag-FWPV157(C218S/C221S). Cells were subsequently treated with 10 mM IPTG for 16 h, ﬁxed and stained with DAPI to visualize the nucleus and virus factories,
anti-HA, and anti-Flag.
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determine the role of FWPV150 and FWPV157 we generated two
p28 RING mutants FWPV150(C196S/C199S) and FWPV157(C218S/
C221S) containing two point mutations critical for ubiquitin ligase
activity (Fig. 3C, panels m–p and u–x). Despite the lack of key
residues within the RING domain, both FWPV150(C196S/C199S)
and FWPV157(C218S/C221S) still accumulated ubiquitin at the
virus factory; however not to the degree of FWPV150 or FWVP157.
Both RING domain mutants demonstrate punctate staining
of conjugated ubiquitin in the cytoplasm, which does not co-
localize at the virus factories (Fig. 3C, panels p and x). These data
suggest that FWPV150 and FWPV157 are ubiquitinated and regu-
lated by another ubiquitin ligase, since the double cysteine
mutants FWPV150(C196S/C199S) and FWPV157(C218S/C221S) lost
the ability to undergo autoubiquitination.
FWPV150 and FWPV157 are ubiquitinated during infection and act as
ubiquitin ligases
Many cellular ubiquitin ligases are regulated by ubiquitination and
subsequent proteasomal degradation (Deshaies and Joazeiro, 2009).
We next investigated whether FWPV150 and FWP157 were regulated
by the ubiquitin–proteasome pathway. HeLa cells were infected with
VACV-HA-Ub at a MOI of 5 and transfected with pSC66-Flag-p28 as a
positive control, pSC66-Flag-FWPV150 or pSC66-Flag-FWPV157. As a
control, cells were also infected with VACV-Flag-FWPV039, an anti-
apoptotic protein that is regulated by ubiquitination (Banadyga et al.,
2007) (Fig. 4A). Cells were lysed in the presence of NEM, a cysteine
peptidase inhibitor that inhibits deubiquitinases, thus preventing the
removal of ubiquitin chains. Flag-tagged proteins were immunopreci-
pitated with mouse anti-Flag M2 and ubiquitination of the proteins
was detected by western blot. Western blots showed high molecular
bands for Flag-p28, Flag-FWPV150, FWPV157 and FWPV039, when
stained against anti-Flag (Fig. 4A), anti-HA (Fig. 4B), and anti-ubiquitin
(Fig. 4C). Overall, these data indicate that FWPV150 and FWPV157 are
ubiquitinated. We performed an in vitro ubiquitination assay to show
that FWPV150 and FWPV157 act as functional ubiquitin ligases and to
further demonstrate the catalytic loss of ubiquitin ligase activity in the
double cysteine mutants FWPV150(C196S/C199S) and FWPV157
(C218S/C221S). Cells were infected with FWPV, transfected with
pSC66-Flag-p28, pSC66-Flag-p28(C173S/C176S), pSC66-Flag-FWPV150,
pSC66-Flag-FWPV150(C196S/C199S), pSC66-Flag-FWPV157, or pSC66-
Flag-FWPV157(C218S/C221S), and were subjected to immunoprecipi-
tation using an anti-Flag antibody. The resulting immunocomplexes
were immobilized on protein G beads, and were used as the source of
ubiquitin ligase and tested in an in vitro ubiquitination assay. The
formation of ubiquitin conjugates was detected by western blotting for
biotinylated ubiquitin adducts. Cell lysates stained with rabbit anti-
Flag showed the presence of all Flag immunoprecipitated proteins. We
previously demonstrated the ubiquitin ligase activity of p28 in an
in vitro ubiquitination assay; at the same time we showed that the
double cysteine mutant p28(C173S/C176S) lost its ubiquitin ligase
activity (Nerenberg et al., 2005). We used p28 as a positive control
and p28(C173S/C176S) as a negative control to investigate the ubiqui-
tin ligase activity of FWPV150, FWPV150(C196S/C199S), FWPV157
(C218S/C221S) and FWPV157 in an in vitro ubiquitination assay.
Immuncomplexes generated from infected/transfected cells expressing
Flag-p28, Flag-FWPV150 and Flag-FWPV157 showed the presence of
both free ubiquitin, as well as high molecular weight ubiquitin
conjugates (Fig. 4D). These highmolecular weight ubiquitin conjugates
were absent in the double cysteine mutants p28(C173S/C176S),
FWPV150(C196S/C199S) and FWPV157(C218S/C221S). This conﬁrms
that FWPV150 and FWPV157 act as ubiquitin ligases and that the
double cysteine mutation abolished their ubiquitin ligase activity.
K48-linked ubiquitin localizes to viral factories in association with
FWPV150 and FWPV157
Lysine-48 (K48) polyubiquitin chains are associated with targeting
proteins for proteasomal degradation (Petroski and Deshaies, 2005).
Therefore, to determine if K48 ubiquitin linkages were present at the
viral factories we used an HA-Ub-K48 construct under the control of a
T7 promoter, lacking all six lysine residues except for lysine 48,
allowing ubiquitin chains to be formed (Komander, 2009; Pickart
and Fushman, 2004). HeLa cells were infected with VVT7, which
expresses the T7 polymerase under the control of an IPTG inducible
promoter, and co-transfected with HA-Ub or HA-K48-Ub along with
pSC66-Flag-FWPV150, pSC66-Flag-FWPV150(C196S/C199S), pSC66-
Flag-FWPV157, or pSC66-Flag-FWPV157(C218S/C221S) (Fig. 5). DAPI
was used to stain the cells in order to visualize the viral factories, and
anti-HA was used to detect ubiquitin. Upon infection and transfection,
both HA-Ub and HA-K48-Ub were found diffuse throughout the
cytoplasm. However, in the presence of the FWPV proteins, both
HA-Ub and HA-K48-Ub co-localized at the virus factory. These data
indicate that FWPV150, FWPV157, and the double-cysteine mutants
promote the enrichment of K48-ubiquitin at the virus factories. K48-
ubiquitin chains result in degradation of target proteins, suggesting
that potential substrates for FWPV150 and FWPV157 are located at the
virus factories. Furthermore, the co-localization of conjugated ubiqui-
tin with the double cysteine mutants of FWPV150 and FWPV157
further indicate the regulation by another ubiquitin ligase.
Fig. 6. FWPV150 is expressed early and FWPV157 is expressed late during FWPV infection. QM5 were infected with FWPV at an MOI of 5 in the absence or presence of 80 μg/
ml AraC. At 4, 12, and 24 h post-infection, total RNA was isolated. Following DNAse treatment, reverse transcription was performed to obtain cDNA, which was subsequently
used as a template for PCR with speciﬁc primers for FWPV037, FWPV085, FWPV150, FWPV157, or GAPDH. PCR reactions were visualized using 1% agarose gel stained with
ethidium bromide.
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FWPV150 and FWPV157 are expressed at different times during
infection
The genome of FWPV encodes two ubiquitin ligases, FWPV150
and FWPV157, therefore we sought to determine if both genes are
actively transcribed during infection by examining mRNA levels
using reverse transcription (RT-PCR) (Fig. 6). QM5 quail cells were
infected with FWPV at an MOI of 5, and RNA was extracted at 4, 12
and 24 h post-infection and subjected to RT-PCR using primers
speciﬁc for each FWPV gene. As a control, we used primers speciﬁc
for an early gene, FWPV037, a protein that resides at the endo-
plasmic reticulum and nuclear membrane (Sing-Chi Lam and M.
Barry, unpublished data), and a late gene, FWPV085, the homo-
logue of VACV I5L (van Buuren et al., 2008). FWPV037 transcripts
were detected at 4, 12 and 24 h post-infection. In the presence of
cytosine arabinoside (AraC), an inhibitor of DNA synthesis and an
inhibitor of poxvirus late gene expression, transcripts were still
detected for early gene FWPV037 (Fig. 6, panel a). Transcripts of
FWPV085 were only detected at 12 and 24 h post-infection, and
treatment with AraC blocked transcription. FWPV150 transcripts
were detected early during infection and also in the presence of
AraC (Fig. 6, panel b), while FWPV157 transcripts were detected
only at 12 and 24 h post-infection and were blocked in the
presence of AraC, identifying FWPV150 as an early gene and
FWPV157 as a late gene (Fig. 6, panel d). Levels of GAPDH
transcripts were similar for all time points and treatments
(Fig. 6, panel e). Overall, the two p28-like ubiquitin ligases are
expressed at different times during FWPV infection, FWPV150 was
transcribed early, whereas FWPV157 was transcribed late.
Discussion
The Poxviridae are a large family of viruses that infect an
exceptionally wide range of vertebrates and invertebrates (Moss,
1996). Recently it has become clear that ubiquitination is an
important mechanism that controls protein degradation via the
ubiquitin–proteasome system (Weissman, 2001). Since ubiquitin
ligases play an important role in substrate recognition and
ubiquitination they are attractive targets for pathogens, including
poxviruses.
We ﬁrst set out to determine if the ubiquitin–proteasome-
system was functional during infection with a number of pox-
viruses, by measuring the chymotrypsin-like activity of the pro-
teasome (Fig. 1). These include VACV, CPXV, ECTV and FWPV in the
presence and absence of MG132. Overall, we detected only a minor
decrease in proteasome function during infection. The fact that the
ubiquitin–proteasome system remains functional indicates a great
advantage for poxviruses to use the cellular systems and encode
its own ubiquitin ligases.
Members of Avipoxviruses contain two ubiquitin ligases (Afonso et
al., 2000; Tulman et al., 2004). Here we demonstrate for the ﬁrst time
that FWPV150 is expressed early, while FWPV157 is expressed late
during infection. Bioinformatics analysis also revealed that canarypox
virus (CNPV) encodes two p28-like ubiquitin ligases, CNPV197 and
CNPV205 (Tulman et al., 2004). Investigation of the upstream
sequences revealed an early promoter for FWPV150 and CNPV197,
and a late promoter upstream of FWPV157 and CNPV205 (B. Bareiss
andM. Barry data not shown). These data suggest that members of the
Avipoxviruses contain two distinct p28-like ubiquitin ligases that are
expressed early and late during virus infection. In contrast, non-
Avipoxviruses encode one p28-like ubiquitin ligase that is expressed
early during infection. The ubiquitin ligase activity of p28 lies in the C-
terminal RING domain, while the N-terminal KilA-N domain is crucial
for its localization to virus factories. Here we demonstrate, that the
double cysteine mutants in the RING domain of FWPV150 and
FWPV157 abolish the ubiquitin ligase activity (Fig. 4D).
Sequence alignments demonstrate highly conserved residues
within the RING domain and KilA-N domain for the poxviral
ubiquitin ligases (Fig. 2). As expected, both p28 homologues in
FWPV, FWPV150 and FWPV157, co-localize with conjugated ubi-
quitin to viral factories during infection (Fig. 3). Moreover, we
demonstrate that FWPV150 and FWPV157 co-localize with K48
ubiquitin chains at the virus factories, which typically leads to
proteasomal degradation of target proteins (Fig. 5). This suggests
that potential substrates are also located at the viral factories and
have the potential to localize in the cytoplasm at early times prior
to formation of virus factories. Surprisingly, the double cysteine
mutants FWPV150(C196S/C199S) and FWPV157(C218S/C221S) still
co-localize with K48 ubiquitin chains. A similar observation was
previously shown for p28(IHDW), where the double cysteine
mutant p28(C173S/C176S) was K48-polyubiquitinated and
degraded by the 26S proteasome (K. Mottet and M. Barry,
unpublished data). We suspect that another ubiquitin ligase of
cellular or viral origin regulates p28 and FWPV homologues as a
feedback mechanism. However, these data do not exclude other
potential polyubiquitin chains such as K63, which lead to altera-
tion of protein function.
There was only a modest localization of conjugated ubiquitin at
the virus factory during FWPV infection (Fig. 3C). We suspect that
overexpression of the FWPV proteins 150 and 157 exaggerate the
phenotype of complete co-localization of conjugated ubiquitin at
the virus factories. Interestingly, during ECTV infection, a portion
of the total cellular pool of conjugated ubiquitin co-localized with
endogenous p28 at the virus factory (data not shown). We
expected a modest co-localization of conjugated ubiquitin with
endogenous FWPV150 or FWPV157 at the virus factory during
wildtype FWPV infection. Unfortunately, in FWPV-infected cells,
we were unable to detect endogenous FWP150 or FWP157 with
the ECTV-speciﬁc p28 antibody due to little sequence homology
(data not shown). Furthermore, RING domain mutants FWPV150
(C196S/C199S) and FWPV157(C218S/C221S) demonstrated a loss of
complete co-localization with conjugated ubiquitin at the virus
factory and punctate staining of ubiquitin was found in the
cytoplasm. We speculate that this intermediate phenotype is due
to the loss of ubiquitin ligase activity and ubiquitin found at the
virus factory is not just due to overexpression of the FWPV
proteins.
The p28 ubiquitin ligases function as virulence factors during
ECTV virus infection (Senkevich et al., 1994, 1995). In order to test
if FWPV150 and FWPV157 are virulence factors during FWPV
infection, an animal model will need to be established. FWPV
cannot infect mammalian cells due to species tropism (Somogyi et
al., 1993). FWPV infects mostly chickens and turkeys, and FWPV
infection typically leads to proliferative lesions in the skin (cuta-
neous form) that progress to thick scabs (Moss, 1996; Tripathy and
Hanson, 1978). In more severe cases, FWPV can lead to lesions in
the upper GI and respiratory tracts (diphtheritic form) (Tripathy
and Hanson, 1978). Overall, it would be interesting to study the
importance of FWPV150 and FWPV157 in vivo to determine if the
lack of one or both FWPV p28-homologues would alter the
virulence of FWPV.
One distinguishing feature of the Avipoxviruses is the large
genome, as exempliﬁed by FWPV (288 kbp) and CNPV (365 kbp)
(Afonso et al., 2000; Tulman et al., 2004). While FWPV and CNPV
are the prototypical members of Avipoxviruses, they exhibit some
interesting genomic differences. Out of the 328 open reading
frames in CNPV, FWPV contains only 209 predicted homologues.
Furthermore, Avipoxviruses encode a number of novel proteins,
which might be important as host-range factors or immune
evasion strategies in birds. In addition to the KilA-N domain
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containing ubiquitin ligases, FWPV150 and FWPV157, there are six
KilA-N only and two KilA-N with C-terminal domains of unknown
function (DUF) in the FWPV genome (Afonso et al., 2000). CNPV
contains 25 KilA-N only ORFs. Interestingly all eight KilA-N
domains and KilA-N-DUF are actively transcribed early during
FWPV infection (B. Bareiss and M. Barry, unpublished data). One
possible function of the KilA-N domains might be to simply bind
the viral DNA in the cytoplasm for protection against anti-viral
host cell sensing. KilA-N-DUF could play a novel immune evasive
role early at the virus factories, or could be important for host
tropism.
Overall, the presence of numerous KilA-N only proteins and
two FWPV-encoded p28-like ubiquitin ligases indicates their
importance during FWPV infection. Future studies will demon-
strate the importance of these novel FWPV proteins during
infection and interaction with host cells.
Conclusions
Our results demonstrate that CNPV and FWPV are the only
poxvirus members that contain two distinct p28-like homologues.
We speculate that the expression of the two ubiquitin ligases differ
in the context of infection and likely have different targets which
are present at early and late times.
Materials and methods
Cells and viruses
HeLa cells were obtained from the American Type Culture Collec-
tion, and grown in Dulbecco's Modiﬁed Eagle Medium (DMEM)
supplemented with 10% fetal bovine serum (FBS), 50 U of penicillin/
ml, 50 mg of streptomycin/ml and 200 mM glutamine (Invitrogen).
Baby Green Monkey Kidney (BGMK) cells were obtained from the
American Type Culture Collection and maintained in DMEM contain-
ing 10% New Born Calf Serum, 50 U of penicillin/ml, 50 mg of
streptomycin/ml and 200 mM glutamine (Invitrogen). Quail ﬁbrosar-
coma (QM5) cells were a generous gift from R. Duncan (Dalhousie
University, Halifax, NS) and maintained in Dulbecco's Modiﬁed Eagle
medium supplemented with 10% fetal bovine serum (Invitrogen), 50 U
of penicillin/ml (Invitrogen), and 200 mM glutamine (Invitrogen). All
cells were grown at 37 1C and 5% CO2. VACVCop and VACVWR were
provided by G. McFadden (University of Florida, Gainesville, FL) and
FWPV was generously provided by D. Evans (University of Alberta,
Edmonton, AB). Recombinant VACVΔF1L-Flag-FPV039 was generated
as previously described (Banadyga et al., 2007). Recombinant VACV-
HA-Ubiquitin was previously described (Nerenberg et al., 2005). All
VACV strains were propagated in BGMK cells and puriﬁed as pre-
viously described (Stuart et al., 1991). VVT7 (WR strain) was provided
by B. Moss (NIH, Bethesda, Maryland). FWPV was propagated in QM5
cells and isolated as previously described (Stuart et al., 1991).
Proteasome assay
HeLa cells (1104) were mock-infected or infected for 14 h with
VACVCop, CPXV, or ECTV at an MOI of 10. QM5 cells (1104) were
mock-infected or infected for 14 h with FWPV at an MOI of 10. Cells
were untreated or treated with 10 μMMG132 at 12 h post-infection
(Sigma-Aldrich). The chymotrypsin-like activity of the proteasome
was assessed using the cell-based Proteasome-Glo assay, according
to the manufacturer’s directions (Promega). Luminescence was
recorded 10 min after the addition of the Proteasome-Glo reagent
using an EnVision 2104 multilabel reader (Perkin-Elmer). The assay
was performed in triplicate, and average relative light units (RLU)
were displayed.
Alignments
Protein alignments for p28(IHDW), ECTV virus strain Moscow
p28(ECTV), canarypox virus p28(CNPV197 and CNPV205), and
fowlpox virus p28(FWPV150 and FWPV157) were performed via
ClustralW (1.82) (http://www.ebi.ac.uk/clustalW/#) (Chenna et al.,
2003). Protein alignments for the KilA-N domains were also
generated by ClustralW (1.82).
Plasmid construction
QM5 (1105) were infected with FWPV at an MOI of 5 and
genomic FWPV DNA was extracted in cell lysis buffer containing
1% SDS, 50 mM Tris pH8.0, 4 mM EDTA, 4 mM CaCl2, and 0.2 mg/
ml proteinase K (Roche). DNA was puriﬁed by phenol extraction
and precipitated with NaOAc containing 95% ethanol. The
FWPV150 gene was ampliﬁed from FWPV DNA and Flag-tagged
by PCR using the primers 50-GTCGACATGGACTACAAAGACGATGAC-
GACAAGTCACATCTTCATCTTAAT-30 (forward) and 50-GCGGCCGC-
TTAACATGATTTTATATATAC-30(reverse). The SalI restriction site
was included in the forward primer and the NotI restriction site
was included in the reverse primer. The FWPV157 gene was
ampliﬁed using the primers 50-GTCGACATGGACTACAAAGACG-
ATGACGACAAGAAGGAGGACGACTCATCA30(forward) and 50-
GCGGCCGCTTATATTTTTATTGTTCTTAT-30(reverse). PCR products
were subcloned into pEGM-T (Promega) and the constructs were
veriﬁed by sequencing at the Applied Genomics Center at the
University of Alberta. Flag-FWPV150, and Flag-FWPV157 were
subcloned into the pSC66 vector, using SalI and NotI, placing the
Flag-tagged genes under the control of a synthetic early/late
poxviral promotor provided by Dr. E. Long (National Institute of
Infectious Diseases, Bethesda). The double cysteine mutant
FWPV150(C196S/C199S) was generated by overlapping PCR using
primers 50-CGATAAATCCGGTATTTCTTTGGATGC-30(forward) and
50-GCATCCAAAGAAATACCGGATTTATCG-30(reverse). FWPV157
(C218S/C221S) was generated by overlapping PCR using primers
50-CCAGTAAAAAGTCTGGCATATCCATAGAAG-30(forward) and 50-
CTTCTATGGATATGCCAGACTTTTTACTGG-30(reverse).
Infection/transfection
QM5 cells (5105) were infected with FWPV at an MOI of 5.
HeLa cells (5105) were infected with VACVCop, VACVWR, or
VACVΔF1L-Flag-FPV039 at a multiplicity of infection (MOI) of 5 for
1 h. Cells were subsequently transfected with 2 mg of pSC66-based
plasmids and 2 ml Lipofectamine 2000 (Invitrogen).
Confocal microscopy
HeLa or QM5 cells (5105) were seeded on 18 mm cover slips
and infected/transfected as described above. Cells were ﬁxed with
4% paraformalydehyde and permeabilized with 1% NP-40 (Sigma-
Aldrich). Cells were stained with rabbit anti-I3L (1:10,000), pro-
vided by D. Evans (University of Alberta, Edmonton, Alberta), or
mouse anti-Flag M2 (1:200) (Sigma-Aldrich) followed by second-
ary staining with goat anti-rabbit Alexa 546 (1:400) (Invitrogen).
To visualize conjugated ubiquitin, cells were stained with anti-FK2
(1:200) (Enzo Life Sciences) followed by staining with goat anti-
mouse Alexa 488 (1:400) (Invitrogen) (Fujimuro et al., 1994). To
detect expression of ubiquitin, HeLa cells were infected with VVT7
at an MOI of 5 and treated with 10 mM isopropyl-β-D-1-thioga-
lactopyranoside (IPTG) to induce T7 polymerase expression. Addi-
tionally, cells were transfected with either HA-Ub-pBluescript or
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HA-K48-Ub-pBluescript, and co-transfected with pSC66-Flag-
FWPV150, pSC66-FWPV(C196S/C199S), pSC66-Flag-FWPV157, or
pSC66-FWPV(C218S/C221S). HeLa cells were stained for Flag to
detect viral proteins and stained with mouse anti-HA (1:200) to
detect ubiquitin. Coverslips were washed with phosphate-buffered
saline (PBS) containing 1% FBS and mounted in 4 mg/ml of N-
propyl gallate (Sigma-Aldrich) in 50% glycerol containing 250 mg/
ml 40, 6-diamidino-2-phenylindole (DAPI) (Invitrogen) to visualize
nuclei and cytoplasmic viral factories. Cells were examined using a
Leica SP5 confocal microscope at 488 nm and 546 nm.
Ubiquitination
To detect ubiquitination, HeLa or QM5 cells (2106) were
infected/transfected with VACVCop or VACVΔF1L-Flag-FPV039 at
an MOI of 5, and 2 mg of the following plasmids; pSC66-Flag-p28
(IHDW), pSC66-Flag-FPV150 or pSC66-Flag-FPV157. Additionally,
VACV-Flag-FPV039 was used as a positive control for ubiquitina-
tion (Banadyga et al., 2007). Cells were lysed in RIPA buffer
containing 5 mM NEM (Sigma-Aldrich), 50 mM Tris–HCl, 1% NP-
40, 0.5% sodium deoxycholate, 0.1% SDS, 150 mM NaCl and EDTA-
free protease inhibitors (Roche Diagnostic). Flag-tagged proteins
were immunoprecipitated and pulled down with protein G beads
(GE Health Care) with mouse anti-Flag M2 (Sigma-Aldrich). We
analysed samples with western blotting with mouse anti-Flag
(Sigma-Aldrich), with mouse anti-HA, or mouse anti-ubiquitin to
detect ubiquitination (Enzo Life Science). To stabilize ubiquitina-
tion, cells were treated with MG132 (10 mM) for 6 h.
in vitro ubiquitination assay
QM5 (2.5106) were infected with FWPV at an MOI of 5 and
transfected with pSC66-Flag-p28, pSC66-Flag-p28(C173S/C176S),
pSC66-Flag-FWPV150, pSC66-Flag-FWPV150(C196S/C199S), pSC66-
Flag-FWPV157, or pSC66-Flag-FWPV157(C218S/C221S). Sixteen hours
post-infection, immunoprecipitations were performed using anti-Flag
M2. Protein G beads were washed with 1% NP-40 lysis buffer and then
additionally washed with (50 mM Tris–HCl pH7.5, 50mM NaCl, 1 mM
EDTA pH8.0, 0.01% NP-40, 10% glycerol) (Furukawa et al., 2002). The
in vitro ubiquitination protocol was followed manufacturer's instruc-
tions (BIOMOL International). The ubiquitination reaction was carried
out in ubiquitination buffer (0.4 mM Tris–HCl, pH7.5), 10 U/ml inor-
ganic pyrophosphatase solution (Sigma-Aldrich), 1 mM DTT, 5 mM
MG-ATP, 50 nM E1, 1.25 μM E2 (UbcH3 or 5), and 1.25 μM Biotiny-
lated-Ub, and was directly added to the Flag-tagged proteins immo-
bilized at the protein G beads. The reactionwas carried out at 37 1C for
90 min and run on a SDS-page gel (Biorad). The western blots were
blocked in 1%BSA/TBST overnight and blotted with Streptavidin-HRP
(Pierce) 1:10,000 dilution to detect ubiquitination.
Reverse transcription PCR (RT-PCR)
RNA transcripts of FWPV150 and FWPV157 were analysed by
reverse transcription polymerase chain reaction (RT-PCR). QM5
cells (1106) were infected with FWPV at an MOI 5 in the absence
or presence of 80 μg/ml of cytosine b-D-arabinofuranoside hydro-
chloride (AraC) (Sigma-Aldrich). At 4, 12, and 24 h post-infection
cells were collected, and RNAwas extracted with TRIZOL according
to the manufacturer's protocol (Invitrogen). To prevent genomic
DNA contamination, isolated RNA was treated with 1 U/ml DNase
for 20 min at room temperature (Invitrogen). The DNase treatment
was inactivated by addition of 1 ml 25 mM EDTA for 10 min at
65 1C. To exclude DNA contamination an aliquot was set aside and
used as a template for control PCR. Reverse transcription was
performed using 1 mg of DNase treated RNA, 200 U of SuperScriptII
reverse transcriptase (Invitrogen), 1 ml 500 mg/ml Oligo-dT
(Invitrogen), 0.2 mM dNTPs (Invitrogen), and 2 mM DTT (Invitro-
gen) and incubated at 42 1C for 50 min, followed by incubation at
70 1C for 15 min. This ﬁrst strand RT reaction cDNA was used as a
template for PCR using the following primers. FWPV forward
primers for FWPV150 forward50-GTCGACATGGACTACAAAGACGAT-
GACGACAAGTCACATCTTCATCTT AAT-30 and FWPV150 reverse 50-
GCGGCCGCTTAACATGATTTTATATATAC-30; FWPV157 forward 50-
GTCGACATGGACTACAAAGACGATGACGACAAGAAGGAGGACGACT-
CATCA-30 and FWPV157 reverse 50-GCGGCCGCTTATATTTTTATT-
GTTCTTAT-30; to show the inhibition of late gene expression in
the presence of AraC, primers speciﬁc to FWPV085, I5L homo-
logue, were used as FWPV085 forward 50-TGGAAATAGCTAGA-
GAAACGCTAA-30 and FWPV085 reverse 50-AAACGAAGTATT-
CTTCCTGCTG-30. As a control for early gene expression, we used
primers speciﬁc to early gene FWPV037, FWPV037 forward 50-
GAATTCATGACGCTATTCGAATATATA-30 and FWPV037 reverse 50-
GGATCCGATTGTGACTTTTCAGACTTTTTACT-30. As a positive control,
GAPDH was ampliﬁed using primers GAPDH forward 50-TGATGA-
CATCAAGAAGGTGGTGAAG-30 and GAPDH reverse 50-TCCTTGGAG-
GCCATGTGGGCCAT-30.
Western blotting
Cell lysates were separated by SDS-PAGE and transferred to
polyvinylidene ﬂuoride membranes (GE Healthcare). Proteins
were detected using rabbit anti-Flag (1:5000), mouse anti-beta-
tubulin (1:1000) (Sigma-Aldrich), or mouse anti-I3L (1:10,000)
provided by D. Evans (University of Alberta, Edmonton, Alberta)
and primary antibodies were detected using donkey anti-rabbit-
HRP (1:40,000) (Jackson ImmunoResearch). Proteins were visua-
lized by enhanced chemiluminescence according to the manufac-
turer's directions (GE Healthcare).
Statistical analysis
Statistical analysis of the results was computed using Prism-
graph. The measurements of relative light units from the protea-
some assay were subjected to analysis using two-way ANOVA to
explore statistical relationships between 7MG132 treatment and
between mock and virus infection. The level of statistical signiﬁ-
cance was set at po0.001.
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